Gary J. Doherty

Cambridge, ENG, GB 
Clinical Trials:Currently Recruiting for 2 Trials
Cambridge, ENG, GB 

Overview

Gary Doherty practices practicing medicine in Cambridge, United Kingdom.

His clinical expertise encompasses SVC Obstruction, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and COVID-19.

He is actively involved in clinical research, co-authoring 38 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Cambridge, ENG, United Kingdom
Other Locations
Belfast, NIR, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A British Feasibility Study of Molecular Stratification and Targeted Therapy to Optimize the Clinical Management of Patients With Glioma by Enhancing Clinical Outcomes, Reducing Avoidable Toxicity, Improving Management of Post-operative Residual & Recurrent Disease and Improving Survivorship
A British Feasibility Study of Molecular Stratification and Targeted Therapy to Optimize the Clinical Management of Patients With Glioma by Enhancing Clinical Outcomes, Reducing Avoidable Toxicity, Improving Management of Post-operative Residual & Recurrent Disease and Improving Survivorship
Enrollment Status: Recruiting
Publish Date: February 20, 2026
Intervention Type: Other
A Phase I, Multicenter Study to Assess the Safety, Tolerability, and Pharmacokinetics of Ascending Doses of AZD1390 in Combination With Radiation Therapy in Patients With Glioblastoma Multiforme and Brain Metastases From Solid Tumors
A Phase I, Multicenter Study to Assess the Safety, Tolerability, and Pharmacokinetics of Ascending Doses of AZD1390 in Combination With Radiation Therapy in Patients With Glioblastoma Multiforme and Brain Metastases From Solid Tumors
Enrollment Status: Recruiting
Publish Date: December 22, 2025
Intervention Type: Radiation, Drug
Study Drug: AZD1390
Study Phase: Phase 1

38 Total Publications

Author Correction: The long-term effects of chemotherapy on normal blood cells.
Author Correction: The long-term effects of chemotherapy on normal blood cells.
Journal: Nature genetics
Published: July 31, 2025

Frequently Asked Questions about Gary J. Doherty

Is Gary J. Doherty a top-rated expert for SVC Obstruction?

MediFind is an objective health platform that identifies experts based on real-world data. Gary J. Doherty is classified as an Experienced expert for SVC Obstruction, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Gary J. Doherty participate in research or clinical trials?

Yes. Gary J. Doherty has published 38 articles and abstracts on conditions like SVC Obstruction. You can view a list of Gary J. Doherty's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Doherty's expertise for a condition
ConditionClose
        View All 16 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile